Lilly's Lechleiter retiring

John Lechleiter intends to retire as president and CEO of Eli Lilly and Co. (NYSE:LLY), effective Dec. 31. David Ricks, SVP and president of Lilly Bio-Medicines, will succeed Lechleiter on Jan. 1, 2017.

Lechleiter, who is also Lilly's chairman, will be non-executive chairman until May 31, 2017, when he will retire from Lilly's board. Ricks will join Lilly's board as he assumes the CEO role, and will become chairman on June 1, 2017. ...